Logo image of REX

REX AMERICAN RESOURCES CORP (REX) Stock Fundamental Analysis

NYSE:REX - New York Stock Exchange, Inc. - US7616241052 - Common Stock - Currency: USD

52.19  +0.78 (+1.52%)

Fundamental Rating

6

Taking everything into account, REX scores 6 out of 10 in our fundamental rating. REX was compared to 211 industry peers in the Oil, Gas & Consumable Fuels industry. While REX has a great health rating, its profitability is only average at the moment. REX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year REX was profitable.
In the past year REX had a positive cash flow from operations.
REX had positive earnings in each of the past 5 years.
Each year in the past 5 years REX had a positive operating cash flow.
REX Yearly Net Income VS EBIT VS OCF VS FCFREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

With a decent Return On Assets value of 8.17%, REX is doing good in the industry, outperforming 78.20% of the companies in the same industry.
REX has a Return On Equity of 10.56%. This is in the better half of the industry: REX outperforms 62.09% of its industry peers.
With a decent Return On Invested Capital value of 7.62%, REX is doing good in the industry, outperforming 64.45% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for REX is significantly below the industry average of 23.70%.
The last Return On Invested Capital (7.62%) for REX is above the 3 year average (6.75%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.17%
ROE 10.56%
ROIC 7.62%
ROA(3y)7.34%
ROA(5y)6.43%
ROE(3y)9.47%
ROE(5y)8.27%
ROIC(3y)6.75%
ROIC(5y)6.3%
REX Yearly ROA, ROE, ROICREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

REX has a Profit Margin (8.86%) which is in line with its industry peers.
REX's Profit Margin has improved in the last couple of years.
REX's Operating Margin of 10.07% is on the low side compared to the rest of the industry. REX is outperformed by 61.14% of its industry peers.
REX's Operating Margin has improved in the last couple of years.
REX has a Gross Margin of 14.29%. This is in the lower half of the industry: REX underperforms 68.25% of its industry peers.
REX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.07%
PM (TTM) 8.86%
GM 14.29%
OM growth 3Y3.74%
OM growth 5Y115.56%
PM growth 3Y10.21%
PM growth 5Y38.58%
GM growth 3Y4.03%
GM growth 5Y23.89%
REX Yearly Profit, Operating, Gross MarginsREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so REX is destroying value.
The number of shares outstanding for REX has been reduced compared to 1 year ago.
REX has less shares outstanding than it did 5 years ago.
REX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
REX Yearly Shares OutstandingREX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
REX Yearly Total Debt VS Total AssetsREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

REX has an Altman-Z score of 6.65. This indicates that REX is financially healthy and has little risk of bankruptcy at the moment.
REX has a Altman-Z score of 6.65. This is amongst the best in the industry. REX outperforms 91.94% of its industry peers.
The Debt to FCF ratio of REX is 0.35, which is an excellent value as it means it would take REX, only 0.35 years of fcf income to pay off all of its debts.
REX has a Debt to FCF ratio of 0.35. This is amongst the best in the industry. REX outperforms 91.94% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that REX is not too dependend on debt financing.
REX has a better Debt to Equity ratio (0.01) than 82.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.35
Altman-Z 6.65
ROIC/WACC0.85
WACC8.93%
REX Yearly LT Debt VS Equity VS FCFREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 9.37 indicates that REX has no problem at all paying its short term obligations.
REX has a Current ratio of 9.37. This is amongst the best in the industry. REX outperforms 96.21% of its industry peers.
REX has a Quick Ratio of 8.65. This indicates that REX is financially healthy and has no problem in meeting its short term obligations.
REX has a better Quick ratio (8.65) than 96.21% of its industry peers.
Industry RankSector Rank
Current Ratio 9.37
Quick Ratio 8.65
REX Yearly Current Assets VS Current LiabilitesREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

4

3. Growth

3.1 Past

REX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.19%.
REX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 54.06% yearly.
The Revenue for REX has decreased by -18.20% in the past year. This is quite bad
REX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.99% yearly.
EPS 1Y (TTM)-5.19%
EPS 3Y4.1%
EPS 5Y54.06%
EPS Q2Q%-11.2%
Revenue 1Y (TTM)-18.2%
Revenue growth 3Y-6.05%
Revenue growth 5Y8.99%
Sales Q2Q%-1.79%

3.2 Future

Based on estimates for the next years, REX will show a decrease in Earnings Per Share. The EPS will decrease by -4.03% on average per year.
REX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.00% yearly.
EPS Next Y-52.42%
EPS Next 2Y-4.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.32%
Revenue Next 2Y10%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
REX Yearly Revenue VS EstimatesREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
REX Yearly EPS VS EstimatesREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

REX is valuated correctly with a Price/Earnings ratio of 15.86.
Compared to the rest of the industry, the Price/Earnings ratio of REX is on the same level as its industry peers.
REX is valuated rather cheaply when we compare the Price/Earnings ratio to 27.28, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 17.22, which indicates a rather expensive current valuation of REX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of REX is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of REX to the average of the S&P500 Index (21.76), we can say REX is valued slightly cheaper.
Industry RankSector Rank
PE 15.86
Fwd PE 17.22
REX Price Earnings VS Forward Price EarningsREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

REX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. REX is cheaper than 74.88% of the companies in the same industry.
REX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 90.42
EV/EBITDA 4.45
REX Per share dataREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

REX has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as REX's earnings are expected to decrease with -4.03% in the coming years.
PEG (NY)N/A
PEG (5Y)0.29
EPS Next 2Y-4.03%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for REX!.
Industry RankSector Rank
Dividend Yield N/A

REX AMERICAN RESOURCES CORP

NYSE:REX (7/3/2025, 11:26:17 AM)

52.19

+0.78 (+1.52%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-20 2025-05-20/bmo
Earnings (Next)08-25 2025-08-25/bmo
Inst Owners88.7%
Inst Owner Change-0.82%
Ins Owners14.04%
Ins Owner Change10.4%
Market Cap867.40M
Analysts80
Price Target51 (-2.28%)
Short Float %4.4%
Short Ratio5.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.29%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)3.38%
Revenue beat(4)2
Avg Revenue beat(4)2.08%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)9.23%
Revenue beat(8)4
Avg Revenue beat(8)2.04%
Revenue beat(12)7
Avg Revenue beat(12)2.33%
Revenue beat(16)10
Avg Revenue beat(16)2.8%
PT rev (1m)0%
PT rev (3m)-16.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)26.67%
EPS NY rev (1m)0%
EPS NY rev (3m)14.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.74%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.04%
Valuation
Industry RankSector Rank
PE 15.86
Fwd PE 17.22
P/S 1.36
P/FCF 90.42
P/OCF 13.77
P/B 1.62
P/tB 1.62
EV/EBITDA 4.45
EPS(TTM)3.29
EY6.3%
EPS(NY)3.03
Fwd EY5.81%
FCF(TTM)0.58
FCFY1.11%
OCF(TTM)3.79
OCFY7.26%
SpS38.48
BVpS32.27
TBVpS32.27
PEG (NY)N/A
PEG (5Y)0.29
Profitability
Industry RankSector Rank
ROA 8.17%
ROE 10.56%
ROCE 9.89%
ROIC 7.62%
ROICexc 14.79%
ROICexgc 14.79%
OM 10.07%
PM (TTM) 8.86%
GM 14.29%
FCFM 1.5%
ROA(3y)7.34%
ROA(5y)6.43%
ROE(3y)9.47%
ROE(5y)8.27%
ROIC(3y)6.75%
ROIC(5y)6.3%
ROICexc(3y)16.25%
ROICexc(5y)14.31%
ROICexgc(3y)16.25%
ROICexgc(5y)14.31%
ROCE(3y)8.77%
ROCE(5y)8.17%
ROICexcg growth 3Y-10.04%
ROICexcg growth 5Y127.29%
ROICexc growth 3Y-10.04%
ROICexc growth 5Y127.29%
OM growth 3Y3.74%
OM growth 5Y115.56%
PM growth 3Y10.21%
PM growth 5Y38.58%
GM growth 3Y4.03%
GM growth 5Y23.89%
F-Score5
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.35
Debt/EBITDA 0.03
Cap/Depr 239.19%
Cap/Sales 8.35%
Interest Coverage 250
Cash Conversion 72.63%
Profit Quality 16.93%
Current Ratio 9.37
Quick Ratio 8.65
Altman-Z 6.65
F-Score5
WACC8.93%
ROIC/WACC0.85
Cap/Depr(3y)192.86%
Cap/Depr(5y)131.33%
Cap/Sales(3y)5.81%
Cap/Sales(5y)4.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.19%
EPS 3Y4.1%
EPS 5Y54.06%
EPS Q2Q%-11.2%
EPS Next Y-52.42%
EPS Next 2Y-4.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.2%
Revenue growth 3Y-6.05%
Revenue growth 5Y8.99%
Sales Q2Q%-1.79%
Revenue Next Year3.32%
Revenue Next 2Y10%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.53%
EBIT growth 3Y-2.54%
EBIT growth 5Y134.95%
EBIT Next Year3.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-77.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.83%
OCF growth 3Y-11.21%
OCF growth 5Y44.19%